Clinical Trial Detail

NCT ID NCT01465802
Title Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer
Indications

lung non-small cell carcinoma

Therapies

Dacomitinib

Alclometasone

Doxycycline

Age Groups: senior adult

Additional content available in CKB BOOST